Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1345

1.

Influence of a Combination of Chemical Enhancers and Iontophoresis on In Vitro Transungual Permeation of Nystatin.

Monti D, Egiziano E, Burgalassi S, Tampucci S, Terreni E, Tivegna S, Chetoni P.

AAPS PharmSciTech. 2018 May;19(4):1574-1581. doi: 10.1208/s12249-018-0977-4. Epub 2018 Feb 26.

PMID:
29484614
2.

Topical Nystatin Treatment for Candida Infection Following Wound Reconstruction.

Lotan AM, Lysy I, Wiener-Well Y, Karni-Shahroor S, Gronovich Y.

Wounds. 2018 Feb;30(2):41-44.

3.

Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.

Rajendran K, Anwar A, Khan NA, Siddiqui R.

ACS Chem Neurosci. 2017 Dec 20;8(12):2626-2630. doi: 10.1021/acschemneuro.7b00430. Epub 2017 Dec 5.

PMID:
29206032
4.

Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.

Neppelenbroek KH, Lima JFM, Hotta J, Galitesi LL, Almeida ALPF, Urban VM.

J Prosthodont. 2018 Feb;27(2):177-181. doi: 10.1111/jopr.12660. Epub 2017 Nov 14.

PMID:
29135059
5.

Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation.

Russo A, Carriero G, Farcomeni A, Ceccarelli G, Tritapepe L, Venditti M.

Mycoses. 2017 Dec;60(12):826-829. doi: 10.1111/myc.12680. Epub 2017 Sep 6.

PMID:
28877374
6.

The Effect of Treatment of Denture-related Stomatitis on Peripheral T Cells and Monocytes.

Maciąg J, Mikołajczyk T, Matusik P, Nowakowski D, Robertson D, Maciąg A, Osmenda G, Cześnikiewicz-Guzik M.

Oral Health Prev Dent. 2017;15(3):259-268. doi: 10.3290/j.ohpd.a38527.

PMID:
28674706
7.

Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients.

Scheibler E, Garcia MCR, Medina da Silva R, Figueiredo MA, Salum FG, Cherubini K.

Gerodontology. 2017 Sep;34(3):291-298. doi: 10.1111/ger.12278. Epub 2017 May 29. Review.

PMID:
28556195
8.

Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams.

Wheat CM, Bickley RJ, Hsueh YH, Cohen BA.

J Pediatr. 2017 Jul;186:192-195.e1. doi: 10.1016/j.jpeds.2017.03.031. Epub 2017 Apr 21.

PMID:
28438376
9.

Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates.

Sharifzadeh A, Khosravi AR, Shokri H, Tari PS.

Microb Pathog. 2017 Jun;107:390-396. doi: 10.1016/j.micpath.2017.04.021. Epub 2017 Apr 19.

PMID:
28431915
10.

Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates.

Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH.

Clin Infect Dis. 2017 May 15;64(10):1387-1395. doi: 10.1093/cid/cix119.

PMID:
28158439
11.

Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation.

Girotra P, Thakur A, Kumar A, Singh SK.

Int J Biol Macromol. 2017 Mar;96:687-696. doi: 10.1016/j.ijbiomac.2016.12.065. Epub 2016 Dec 29.

PMID:
28041915
12.

Topical Antimycotics for Oral Candidiasis in Warfarin Users.

Hellfritzsch M, Pottegård A, Pedersen AJ, Burghle A, Mouaanaki F, Hallas J, Grove EL, Damkier P.

Basic Clin Pharmacol Toxicol. 2017 Apr;120(4):368-372. doi: 10.1111/bcpt.12722. Epub 2017 Jan 11.

13.

The Effect of Nystatin Solution on Otoacoustic Emissions in Rats.

Vural A, Şahin Mİ, Aydın M, Gündoğdu R, Arlı T, Okuducu H, Dizdar D, Külahlı İ.

J Int Adv Otol. 2017 Apr;13(1):105-109. doi: 10.5152/iao.2016.1667. Epub 2016 Nov 7.

14.

Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.

Ellepola AN, Jayathilake JA, Sharma PN, Khan ZU.

J Investig Clin Dent. 2016 Nov;7(4):424-430. doi: 10.1111/jicd.12167. Epub 2015 Jun 9.

PMID:
26059506
15.

Intraoral Device for Optimal Antifungal Delivery in a Rat Model.

Hotta J, Cral WG, Sakima VT, Lara VS, Urban VM, Neppelenbroek KH.

Curr Drug Deliv. 2017;14(5):658-667. doi: 10.2174/1567201813666161013122115.

PMID:
27739378
16.

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RA; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Team.

AIDS. 2017 Jan 2;31(1):81-88.

17.

[POLYGYNAX IN THE TREATMENT OF VAGINAL INFECTIONS IN PREGNANT AND NON-PREGNANT WOMEN--CLINICAL EXPERIENCE].

Popovski N, Popovski K, Nedelkovski V.

Akush Ginekol (Sofiia). 2016;55 Suppl 1 Pt 2:3-4. Bulgarian.

PMID:
27509660
18.

Nystatin and lidocaine pastilles for the local treatment of oral mucositis.

Silva FC, Marto JM, Salgado A, Machado P, Silva AN, Almeida AJ.

Pharm Dev Technol. 2017 Mar;22(2):266-274. doi: 10.1080/10837450.2016.1221424. Epub 2016 Aug 30.

PMID:
27499389
19.

Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin.

Pemberton MN.

Oral Dis. 2016 Nov;22(8):761-765. doi: 10.1111/odi.12541. Epub 2016 Aug 8.

PMID:
27416928
20.

Management of candidemia in patients with Clostridium difficile infection.

Falcone M, Venditti M, Sanguinetti M, Posteraro B.

Expert Rev Anti Infect Ther. 2016 Jul;14(7):679-85. doi: 10.1080/14787210.2016.1197118. Review.

PMID:
27254270

Supplemental Content

Loading ...
Support Center